Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is cytomegalovirus viraemia a useful tool in managing CMV disease?

× No keyword cloud information.

30 in total

1. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.

Authors: F J Torriani; W R Freeman; J C Macdonald; M P Karavellas; D M Durand; D D Jeffrey; P R Meylan; R D Schrier
Journal: AIDS Date: 2000-01-28 Impact factor: 4.177

2. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.

Authors: D Salmon-Céron; M C Mazeron; S Chaput; N Boukli; B Senechal; N Houhou; C Katlama; S Matheron; A M Fillet; J Gozlan; C Leport; V Jeantils; F Freymuth; D Costagliola
Journal: AIDS Date: 2000-05-26 Impact factor: 4.177

3. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections.

Authors: S Stagno; D W Reynolds; A Tsiantos; D A Fuccillo; W Long; C A Alford
Journal: J Infect Dis Date: 1975-11 Impact factor: 5.226

4. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.

Authors: S M Whitcup; E Fortin; A S Lindblad; P Griffiths; J A Metcalf; M R Robinson; J Manischewitz; B Baird; C Perry; I M Kidd; T Vrabec; R T Davey; J Falloon; R E Walker; J A Kovacs; H C Lane; R B Nussenblatt; J Smith; H Masur; M A Polis
Journal: JAMA Date: 1999-11-03 Impact factor: 56.272

5. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.

Authors: J R Deayton; P Wilson; C A Sabin; C C Davey; M A Johnson; V C Emery; P D Griffiths
Journal: AIDS Date: 2000-06-16 Impact factor: 4.177

6. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.

Authors: S A Spector; R Wong; K Hsia; M Pilcher; M J Stempien
Journal: J Clin Invest Date: 1998-01-15 Impact factor: 14.808

7. Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation.

Authors: A V Cope; C Sabin; A Burroughs; K Rolles; P D Griffiths; V C Emery
Journal: J Infect Dis Date: 1997-12 Impact factor: 5.226

8. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.

Authors: J L Casado; J Arrizabalaga; M Montes; P Martí-Belda; C Tural; J Pinilla; C Gutierrez; J Portu; R Schuurman; K Aguirrebengoa
Journal: AIDS Date: 1999-08-20 Impact factor: 4.177

9. Natural history of untreated cytomegalovirus retinitis.

Authors: E F Bowen; P Wilson; M Atkins; S Madge; P D Griffiths; M A Johnson; V C Emery
Journal: Lancet Date: 1995 Dec 23-30 Impact factor: 79.321

10. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.

Authors: S A Spector; G F McKinley; J P Lalezari; T Samo; R Andruczk; S Follansbee; P D Sparti; D V Havlir; G Simpson; W Buhles; R Wong; M Stempien
Journal: N Engl J Med Date: 1996-06-06 Impact factor: 91.245

1 in total

1. Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients.

Authors: Adrian Egli; Juliane Schäfer; Michael Osthoff; Steffen Thiel; Christina Mikkelsen; Andri Rauch; Hans H Hirsch; Heiner C Bucher; James Young; Jens C Jensenius; Manuel Battegay; Marten Trendelenburg
Journal: PLoS One Date: 2013-01-04 Impact factor: 3.240

1 in total